Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Joe Biden to Receive First Dose of Pfizer/BioNTech Vaccine on Monday

By Eric Volkman - Dec 18, 2020 at 5:23PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The current president, however, hasn't yet received his shot.

The most high-profile American in 2021 is going to receive his initial dose of Pfizer ( PFE 2.45% ) and BioNTech's ( BNTX -6.72% ) coronavirus vaccine as 2020 fades away. President-Elect Joe Biden will receive his first jab on Monday, his incoming press secretary Jen Psaki announced, in an unnamed medical facility in Delaware. Wife and soon-to-be-Second Lady Jill Biden will receive her shot along with him.

The vaccine is the first to receive Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). Current high-level government officials have already received their initial doses, notably Vice President Mike Pence, who along with Second Lady Karen Pence was jabbed on Friday. President Donald Trump has not yet received one.

A syringe being filled with a vaccine from a vial.

Image source: Getty Images.

Other Biden administration figures will receive their first shots of the vaccine in the very near future. Vice President-Elect Kamala Harris and incoming Second Gentleman Doug Emhoff are slated to get theirs the week after Christmas.

Pfizer/BioNTech's vaccine is administered in a two-dose regimen, with the booster coming three weeks after the first shot.

The vaccine is currently being distributed throughout the country. At the moment, due to the still-limited supply, inoculation has essentially been restricted to healthcare professionals, high-level government employees, and in certain cases to immediate family members in both categories.

The idea behind these high-profile inoculations, of course, is to instill confidence in Pfizer and BioNTech's vaccine. It's encouraging that both members of the current and the incoming administrations -- with the exception of President Trump -- are being jabbed.

On Friday, however, both Pfizer and BioNTech stocks sank. The former was down by 0.9% and the latter 2.1% against only a 0.4% slide in the S&P 500 index on the day.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
$53.69 (2.45%) $1.28
BioNTech SE Stock Quote
BioNTech SE
$338.17 (-6.72%) $-24.35

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.